Kali Therapeutics
PrivateLast Round
Strategic
Mar 23, 2026
Total Funding Raised
$180M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Kali Therapeutics is a biotechnology company that develops trispecific T-cell engager therapies designed to reset the immune system for the treatment of autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kali Therapeutics Comparables
Compare Kali Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oblenio Bio | 91% | |
| Boulevard Bio | 89% | |
| Excalipoint Therapeutics | 82% | |
Kali Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Mar 23, 2026 |
Key People
Founding team and executive leadership
Kali Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LYFE Capital | Seed, Early Funding, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 13, 2026
Open roles increased from 0 to 7, representing 88% of headcount.
Kali Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kali Therapeutics's valuation, stock price, and market status.